Review: platelet matching for alloimmunized patients—room for improvement
By:
Paid access
|May 2020References
- Myhre, BA. The first recorded blood transfusions: 1656–1688. Transfusion 1990;30:358-62.
- Myhre BA. James Blundell—pioneer transfusionist. Transfusion 1995;35:74-8.
- Oberman HA. The crossmatch. A brief historical perspective. Transfusion 1981;21:645-51.
- Crile GW. Hemorrhage and Transfusion. New York: D. Appleton & Co., 1909:318.
- Hektoen L. Isoagglutination of human corpuscles. JAMA 1907;48:1739.
- Ottenberg R. Transfusion and arterial anastamosis. Am J Surg 1908;47:486.
- Epstein AA, Ottenberg R. A method for hemolysis and agglutinin tests. Arch Intern Med 1909;3:286.
- Moss, WL. Studies on isoagglutination and isohemolysis. Bull J Hopk Hosp 1910;21:63.
- Lee RI. A simple and rapid method for the selection of suitable donors for transfusion by the determination of blood groups. Br Med J 1917; 2:684.
- Rachel JM, Summers TC, Sinor LT, Plapp FV. Use of a solid phase red blood cell adherence method for pretranfusion platelet compatibility testing, Am J Clin Pathol 1988;90:63-8.
- Diamond LK, Denton RL. Rh agglutination in various media with particular reference to the value of albumin. J Lab Clin Med 1945;30:821.
- Coombs RR, Mourant AE, Race R.A new test for the detection of weak and “incomplete” Rh agglutinins. Br J Exp Pathol 1945;26:255-66.
- Bishop JF, Matthews JP,Yuen K, et al. The definition of refractoriness to platelet transfusions. Transfus Med 1992;2:35-41.
- Bishop JF, McGrath K, Wolf MM, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988;71:383-7.
- Yankee RA, Grumet FC, Rogentine GN. Platelet transfusion. The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing. N Engl J Med 1969;281:1208-12.
- Duquesnoy RJ, Filip DJ, Rodey GE, et al. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977;2:219-26.
- Hogge DE, Dutcher JP, Aisner J, Schiffer CA. Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 1983;14:363-9.
- McFarland JG, Anderson AJ, Slichter SJ. Factors inf luencing the transfusion response to HLA- selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989;73:380-6.
- Phekoo KJ, Hambley H, Schey SA, et al. Audit of practice in platelet refractoriness. Vox Sang 1997;73:81-6.
- Engelfriet CP, Reesink HW, Aster RH, et al. Management of alloimmunized, refractory patients in need of platelet transfusions. Vox Sang 1997;73:191-8.
- Murphy S, Varma M. Selecting platelets for transfusion of the alloimmunized patient: A review. Immunohematology 1998;14:117-23.
- Duquesnoy RJ. HLA Matchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 202;63:339-52.
- Duquesnoy RJ, Marrari M. HLA Matchmaker: A molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol 202;63:353-63.
- Gelb AB, Leavitt AD. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets. Transfusion 1997;37:624-30.
- Petz LD, Garratty G, Calhoun L, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 200;40:1446-56.
- Lee EJ, Schiffer CA. Serial measurement of lymphocytotoxic antibody and response to nonmatched platelet transfusions in alloimmunized patients. Blood 1987;70:1727-9.
- Terasaki PI, Marchioro TL, Starzl TE. Sero-typing of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. In: Histocompatibility Testing. Report of a Conference and Workshop. Washington DC: National Academy of Sciences—National Research Council 1965: 83-96.
- Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966;2(7465):662-5.
- Terasaki PI. Humoral theory of transplantation. Am J Transplant 203;3:665-73.
- Rodey G. HLA beyond tears: introduction to human histocompatibility. 2nd ed. Durango, CO: De Novo, Inc., 200: Chapters 4, 8, 9 and 10.
- Rodey GE, Revels K, Fuller TC. Epitope specificity of HLA Class I alloantibodies. II. Stability of crossreactive group antibody patterns over extended time periods. Transplantation 1997;63:885-93.
- Rodey GE, Neylan JF, Whelchel JD, et al. Epitope specificity of HLA Class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994;39:272-80.
- Meny GM, Hsu S, Murphy S, Pei R. ELISA and flow cytometr y provide advantages over lympho- cytotoxicity in detecting HLA antibodies. (In preparation) 204.
- Scornik JC, Ireland JE, Howard RJ, Pfaff WW. Assessment of the risk for broad sensitization by blood transfusions. Transplantation 1984;37: 249-53.
- Braun, W.E. Donor-specific antibodies. Clinical relevance of antibodies detected in lymphocyte crossmatches. Clin Lab Med 1991:11:571-602.
- Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204: 998-100.
- Amos DB, Bashir H, Boyle W, et al. A simple micro cytotoxicity test. Transplantation 1969;7:220-3.
- Johnson AH, Rossen RD, Butler WT. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection. Tissue Antigens 1972;2:215-26.
- Fuller TC, Fuller AA, Golden M, Rodey GE. HLA alloantibodies and the mechanism of the antiglobulin-augmented lymphocytotoxicity procedure. Hum Immunol 1997;56:94-105.
- Yunis EJ, Ward FE, Amos DB. Observations on the CYNAP phenomenon. In: Terasaki PI, ed. Histocompatibility 1970. Copenhagen: Munksgaard, 1970:351-6.
- Kao KJ, Scornik JC, Small SJ. Enzyme-linked immunoassay for anti-HLA antibodies—an alternative to panel studies by lymphocytotoxicity. Transplantation 1993;55:192-6.
- Wang G, Tarsitani C, Denham S, Chen M, Lee J-H. A new micro-ELISA for anti-Class I and Class II antibody detection. Human Immunol 1998:59(1): 133.
- Garovoy MR, Rheinschmidt MA, Bigos M, et al. Flow cytometry analysis: A high technology crossmatch technique facilitating transplantation. Transplant Proc 1983;15:1939-44.
- Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA Class I and Class II antibodies screening with f low cytometry. Human Immunol 1998;59:313-22.
- Pei R, Lee J, Chen T, et al. Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol 1999;60:1293-1302.
- Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen f low cytometr y beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 203;75:43-9.
- Visuals of the Clinical Histocompatibility Workshop, Cancun, Mexico 202, Hawaii 203, sponsored by One Lambda, Inc. Paul Terasaki, Ed.
- Tambur AR, Bray RA, Takeomoto SK, et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 200;70:1055-9.
- Gebel HM, Bray RA. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 200;69:1370-4.
- Gebel HM, Bray RA, Nickerson P. Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant 203;3: 1488-1500.
DOI: https://doi.org/10.21307/immunohematology-2019-429 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 80 - 88
Published on: May 15, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2020 S.T. Nance, S. Hsu, R.R. Vassallo, S. MURPHY, published by American National Red Cross
This work is licensed under the Creative Commons License.